Filing search / Teva Pharmaceutical Industries Limited / "Access" / Page 28

6-K

8qtodzn4ox

3 May 05

Teva Reports First Quarter 2005 Results

12:00am

6-K

yyuqlosq 9694mpg

15 Feb 05

Teva Reports Record Sales and Net Income for Q4 2004

12:00am

6-K

680ms 5tdaffw3clrfo8

3 Feb 05

Teva to Report 2004 Financial Results on February 15, 2005

12:00am

6-K

z7isryv

4 Nov 04

Teva to Broadcast Third Quarter 2004 Earnings Luncheon on the Web

12:00am

6-K

u7935otgdcr

4 Nov 04

Teva Reports Record Q3 Sales, Net Income, Eps and Cash Flow

12:00am

6-K

zlhxz

18 Oct 04

Teva to Report Third Quarter 2004 Financial Results on November 4, 2004

12:00am

6-K

44if4iz4mnilvcr

3 Aug 04

Teva Reports Record Sales and Net Income In Q2

12:00am

6-K

zhe5m4k0hduo3

20 Jul 04

Teva to Report Second Quarter 2004 Financial Results on August 3, 2004

12:00am

6-K

voipmsasm81rn

4 May 04

Teva Q1 2004 Sales Exceed $ 1 Billion for the First Time

12:00am

6-K

39njy

28 Apr 04

4 PR'S - Conference Call +Flumazenil +Levofloxacin + Carboplatin

12:00am

6-K

au9i8x q6all4i

17 Feb 04

Teva Reports Record Sales and Net Income for Q4 2003 , Record Annual Sales of $ 3.3 Billion

12:00am

6-K

uyb7w80k

2 Feb 04

2 Press Releases:teva Comments on the Court of Appeals Decision Regarding Moexipril and Teva to Report Fourth Quarter 2003 Financial Results

12:00am

6-K

EX-1.1

x1bg38i

27 Jan 04

Report of Foreign Private Issuer

12:00am

424B5

9zov aiptz

23 Jan 04

Prospectus supplement for primary offering

12:00am

424B5

7bxa5oj0bry

22 Jan 04

Prospectus supplement for primary offering

12:00am

6-K

k6q4 45on08l

22 Jan 04

2 Press Releases: Teva Completes Acquisition of Sicor + Teva Announces Pricing of $1 Billion Convertible Debenture Offering

12:00am

F-4/A

het02fa wdp6evqkg

12 Dec 03

Registration of securities (foreign) (amended)

12:00am

F-4

1yq5t7 lkdzbnac3

26 Nov 03

Registration of securities (foreign)

12:00am